Should I buy Hanover Insurance (THG) stock or is it too late?

Hanover Insurance · Financials · price $228
Logo Hanover InsuranceSee the full Hanover Insurance (THG) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: RBC Capital77% of its targets hit on this sector (172 calls tested). It aims for $235 (+3.2 %), call made on July 31, 2026, maturing on July 31, 2027 (28 d ago).

The 3 reliable analysts $222-2.5 %
The 4 other firms $230+1.0 %
How to read it: the 3 reliable firms are not filtered by optimism — 1 aim above the price, 2 below, hence their $222 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Hanover Insurance

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Oppenheimer100 %+22.8 %5$220 -3%
Piper Sandler93 %+21.4 %14$220 -3%
JMP Securities88 %+16.5 %17$200 -12%
In short — Should you invest in Hanover Insurance? Is it too late, still worth it? Analysts are split (29% buy, median target $222, i.e. -2%). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • Pays a dividend (1.7% yield), raised for 5 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

  • Even the most reliable firm on THG, Oppenheimer (100% hit rate, 5 scored calls), only targets $220 (call made on May 21, 2026, maturing on May 21, 2027) (-3%) in its most recent call. The stock may already have run past its target.
  • The consensus is not unanimous: of 7 ratings, 5 are neutral.
  • Limited upside: the median target is only -2% from the current price.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on THG

Median target $222 (-2%) · 7 ratings · Hold consensus

Strong Buy00%
Buy229%
Hold571%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Hanover Insurance now?

We won't decide for you. The facts: 29% of analysts rate it a buy, median target $222 (-2%), and Oppenheimer (most reliable on THG, 100%) targets $220. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Hanover Insurance?

The stated upside is small: the median target ($222) sits just -2% from the price ($228) (most reliable on THG: Oppenheimer, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Hanover Insurance still worth investing in?

It depends on the gap between the price ($228) and its estimated value: analysts target $222 on median (-2%), with 29% buys (most reliable on THG: Oppenheimer, 100%). Cross-check with their real reliability on THG and the cautions above. Information, not advice.

What's the main risk in buying THG?

Even the most reliable firm on THG, Oppenheimer (100% hit rate, 5 scored calls), only targets $220 (call made on May 21, 2026, maturing on May 21, 2027) (-3%) in its most recent call. The stock may already have run past its target.

→ Go deeper: the full Hanover Insurance profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)